Skip to main content
Top

Breast Cancer Research

Issue 4/2002

Content (11 Articles)

Commentary

Estrogen as therapy for breast cancer

James N Ingle

Commentary

Defining the galaxy of gene expression in breast cancer

Edison T Liu, Christos Sotiriou

Open Access Research article

Novel mutations in the BRCA1 and BRCA2genes in Iranian women with early-onset breast cancer

Vahid R Yassaee, Sirous Zeinali, Iraj Harirchi, Soghra Jarvandi, Mohammad A Mohagheghi, David P Hornby, Ann Dalton

Open Access Research article

A49T, V89L and TA repeat polymorphisms of steroid 5α-reductase type II and breast cancer risk in Japanese women

Chunxia Yang, Nobuyuki Hamajima, Hiroji Iwata, Toshiko Saito, Keitaro Matsuo, Kaoru Hirose, Manami Inoue, Toshiro Takezaki, Kazuo Tajima

Viewpoint

Wnt signalling in mammary carcinogenesis

Valerie Speirs

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine